Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression

Neuropsychopharmacology

Volumn 27, Issue 5, 2002, Pages 874-878

  Padberg, Frank ^a   Di Michele, Flavia ^b   Zwanzger, Peter ^a   Romeo, Elena ^b   Bernardi, Giorgio ^b   Schüle, Cornelius ^a   Baghai, Thomas C ^a   Ella, Robin ^a   Pasini, Augusto ^b   Rupprecht, Rainer ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Affective disorders; Antidepressant treatment; Neuroactive steroids; Prefrontal cortex; TMS; Transcranial magnetic stimulation

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 3ALPHA,5BETA TETRAHYDROPROGESTERONE; 3BETA,5ALPHA TETRAHYDROPROGESTERONE; ANTIDEPRESSANT AGENT; PRASTERONE; PROGESTERONE; PROGESTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR DEPRESSION; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; ANALYSIS OF VARIANCE; DEHYDROEPIANDROSTERONE; DEPRESSIVE DISORDER, MAJOR; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGESTERONE; STEROIDS;

EID: 0036846298     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(02)00355-X     Document Type: Article

References (24)

1. Ben-Shachar D., Gazawi H., Riboyad-Levin J., Klein E. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res. 816:1999;78-83.
2. Berman R.M., Narasimhan M., Sanacora G., Miano A.P., Hoffman R.E., Hu X.S., Charney D.S., Boutros N.N. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry. 47:2000;332-337.
3. Fleischmann A., Prolov K., Abarbanel J., Belmaker R.H. The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression. Brain Res. 699:1995;130-132.
4. George M.S., Guidotti A., Rubinow D., Pan B., Mikalauskas K., Post R.M. CSF neuroactive steroids in affective disorders. pregnenolone, progesterone and DBI Biol Psychiatry. 35:1994;775-780.
5. George M.S., Nahas Z., Molloy M., Speer A.M., Oliver N.C., Li X.-B., Arana G.W., Risch S.C., Ballenger J.C. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry. 48:2000;962-970.
6. Griffin L.D., Mellon S.H. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA. 96:1999;13512-13517.
7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
8. Keck M.E., Engelmann M., Müller M.B., Henniger M.S.H., Hermann B., Rupprecht R., Neumann I.D., Toschi N., Landgraf R., Post A. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiatr Res. 34:2000;265-276.
9. Khisti R.T., Chopde C.T., Jain S.P. Antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice forced swim test. Pharmacol Biochem Behav. 67:2000;137-143.
10. Khisti R.T., Chopde C.T. Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice. Brain Res. 865:2000;291-300.
11. Klein E., Kreinin I., Chistyakov A., Koren D., Mecz L., Marmur S., Ben-Shachar D., Feinsod M. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression. Arch Gen Psychiatry. 56:1999;315-320.
12. 1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res. 826:1999;309-312.
13. Maayan R., Yagorowski Y., Grupper D., Weiss M., Shtaif B., Kaoud M.A., Weizman A. Basal plasma dehydroepiandrosterone sulfate level. a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients Biol Psychiatry. 48:2000;693-701.
14. Padberg F., Schüle C., Zwanzger P., Baghai T., Ella R., Mikhaiel P., Hampel H., Möller H.J., Rupprecht R. Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression. J Psychiatr Res. 36:2002;131-135. a.
15. Padberg F., Zwanzger P., Keck M.E., Kathmann N., Mikhaiel P., Ella R., Rupprecht P., Thoma H., Hampel H., Toschi N., Möller H.J. Repetitive transcranial magnetic stimulation (rTMS) in major depression. relation between efficacy and stimulation intensity Neuropsychopharmacology. in press:2002;. b.
16. Romeo E., Strohle A., Spalletta G., di Michele F., Hermann B., Holsboer F., Pasini A., Rupprecht R. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry. 155:1998;910-913.
17. Rupprecht R., di Michele F., Hermann B., Strohle A., Lancel M., Romeo E., Holsboer F. Neuroactive steroids. molecular mechanisms of action and implications for neuropsychopharmacology Brain Res Rev. 37:2001;59-67.
18. Rupprecht R., Holsboer F. Neuroactive steroids. mechanisms of action and neuropsychopharmacological perspectives Trends Neurosci. 22:1999;410-416.
19. Strohle A., Romeo E., di Michele F., Pasini A., Yassouridis A., Holsboer F., Rupprecht R. GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry. 159:2002;145-147.
20. Urani A., Roman F.J., Phan V.L., Su T.P., Maurice T. The antidepressant-like effect induced by sigma(1)-receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther. 298:2001;1269-1279.
21. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA. 93:1996;12599-12604.
22. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA. 95:1998;3239-3244.
23. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 156:1999;646-649.
24. Zyss T., Gorka Z., Kowalska M., Vetulani J. Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat. Biol Psychiatry. 42:1997;920-924.